Annual EBITDA
-$44.94 M
+$162.70 M+78.36%
December 31, 2024
Summary
- As of March 14, 2025, CLOV annual EBITDA is -$44.94 million, with the most recent change of +$162.70 million (+78.36%) on December 31, 2024.
- During the last 3 years, CLOV annual EBITDA has risen by +$524.66 million (+92.11%).
- CLOV annual EBITDA is now at all-time high.
Performance
CLOV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$21.14 M
-$12.69 M-150.26%
December 31, 2024
Summary
- As of March 14, 2025, CLOV quarterly EBITDA is -$21.14 million, with the most recent change of -$12.69 million (-150.26%) on December 31, 2024.
- Over the past year, CLOV quarterly EBITDA has stayed the same.
- CLOV quarterly EBITDA is now -179.55% below its all-time high of $26.57 million, reached on September 30, 2020.
Performance
CLOV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$44.12 M
+$46.13 M+51.12%
December 31, 2024
Summary
- As of March 14, 2025, CLOV TTM EBITDA is -$44.12 million, with the most recent change of +$46.13 million (+51.12%) on December 31, 2024.
- Over the past year, CLOV TTM EBITDA has stayed the same.
- CLOV TTM EBITDA is now -242.82% below its all-time high of $30.89 million, reached on September 30, 2020.
Performance
CLOV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CLOV EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +78.4% | 0.0% | 0.0% |
| 3 y3 years | +92.1% | +88.6% | +92.3% |
| 5 y5 years | +86.1% | +88.6% | +92.3% |
CLOV EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +92.1% | -381.8% | +88.6% | at high | +92.8% |
| 5 y | 5-year | at high | +92.1% | -179.6% | +93.3% | -242.8% | +92.8% |
| alltime | all time | at high | +92.1% | -179.6% | +93.3% | -242.8% | +92.8% |
Clover Health Investments EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$44.94 M(-78.4%) | -$21.14 M(+150.3%) | -$44.12 M(-51.1%) |
| Sep 2024 | - | -$8.45 M(-212.6%) | -$90.25 M(-21.4%) |
| Jun 2024 | - | $7.50 M(-134.0%) | -$114.86 M(-23.6%) |
| Mar 2024 | - | -$22.03 M(-67.2%) | -$150.25 M(-27.0%) |
| Dec 2023 | -$207.63 M(-17.6%) | -$67.27 M(+103.5%) | -$205.82 M(+48.6%) |
| Sep 2023 | - | -$33.06 M(+18.6%) | -$138.50 M(-23.0%) |
| Jun 2023 | - | -$27.88 M(-64.1%) | -$179.90 M(-29.6%) |
| Mar 2023 | - | -$77.61 M(<-9900.0%) | -$255.38 M(+1.3%) |
| Dec 2022 | -$252.03 M | $55.00 K(-100.1%) | -$252.03 M(-42.5%) |
| Sep 2022 | - | -$74.46 M(-28.0%) | -$438.03 M(+10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$103.37 M(+39.2%) | -$397.55 M(-34.9%) |
| Mar 2022 | - | -$74.26 M(-60.1%) | -$610.44 M(+7.2%) |
| Dec 2021 | -$569.60 M(+623.5%) | -$185.94 M(+447.2%) | -$569.60 M(+15.5%) |
| Sep 2021 | - | -$33.98 M(-89.3%) | -$493.30 M(+14.0%) |
| Jun 2021 | - | -$316.26 M(+846.3%) | -$432.74 M(+343.2%) |
| Mar 2021 | - | -$33.42 M(-69.5%) | -$97.64 M(+24.0%) |
| Dec 2020 | -$78.73 M(-75.7%) | -$109.64 M(-512.6%) | -$78.73 M(-354.9%) |
| Sep 2020 | - | $26.57 M(+41.0%) | $30.89 M(+615.5%) |
| Jun 2020 | - | $18.85 M(-229.9%) | $4.32 M(-129.7%) |
| Mar 2020 | - | -$14.51 M(>+9900.0%) | -$14.53 M(>+9900.0%) |
| Dec 2019 | -$324.12 M | -$17.60 K | -$17.60 K |
FAQ
- What is Clover Health Investments annual EBITDA?
- What is the all time high annual EBITDA for Clover Health Investments?
- What is Clover Health Investments annual EBITDA year-on-year change?
- What is Clover Health Investments quarterly EBITDA?
- What is the all time high quarterly EBITDA for Clover Health Investments?
- What is Clover Health Investments quarterly EBITDA year-on-year change?
- What is Clover Health Investments TTM EBITDA?
- What is the all time high TTM EBITDA for Clover Health Investments?
- What is Clover Health Investments TTM EBITDA year-on-year change?
What is Clover Health Investments annual EBITDA?
The current annual EBITDA of CLOV is -$44.94 M
What is the all time high annual EBITDA for Clover Health Investments?
Clover Health Investments all-time high annual EBITDA is -$44.94 M
What is Clover Health Investments annual EBITDA year-on-year change?
Over the past year, CLOV annual EBITDA has changed by +$162.70 M (+78.36%)
What is Clover Health Investments quarterly EBITDA?
The current quarterly EBITDA of CLOV is -$21.14 M
What is the all time high quarterly EBITDA for Clover Health Investments?
Clover Health Investments all-time high quarterly EBITDA is $26.57 M
What is Clover Health Investments quarterly EBITDA year-on-year change?
Over the past year, CLOV quarterly EBITDA has changed by $0.00 (0.00%)
What is Clover Health Investments TTM EBITDA?
The current TTM EBITDA of CLOV is -$44.12 M
What is the all time high TTM EBITDA for Clover Health Investments?
Clover Health Investments all-time high TTM EBITDA is $30.89 M
What is Clover Health Investments TTM EBITDA year-on-year change?
Over the past year, CLOV TTM EBITDA has changed by $0.00 (0.00%)